Peer Review History
| Original SubmissionFebruary 26, 2020 |
|---|
|
PONE-D-20-05638 “It’s just an issue and you deal with it… you just deal with it, you move on and you do it together.”: Male experiences of Bacterial Vaginosis and the acceptability of associated male partner treatment. PLOS ONE Dear Dr Wigan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by 30 May 2020. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Tania Crucitti Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. PLOS ONE does not copy edit accepted manuscripts. Therefore, the language in submitted articles must be clear, correct, and unambiguous (http://journals.plos.org/plosone/s/criteria-for-publication#loc-5). We notice that your manuscript contains offensive terms in some of the quotes. We would like you to reduce the number of offensive terms in this manuscript and don't think that these verbatim examples have to be printed to make the points made in your manuscript. Please remove the offensive words on page 16 and 32 and generally make sure that there is only a minimal number of offensive terms in your manuscript and only where absolutely scientifically necessary. 3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified how verbal consent was documented and witnessed. 4. Please include additional information regarding the interview guide used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a guide as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The author fills an important knowledge gap of male perspectives on their partner’s BV infection, how that affects their relationship with their partner and what attitudes they have about getting treatment for BV, a condition that has typically has no effect on them physically but may give better recovery results for their partners. Major: - Ethics section needs more details particularly around confidentiality - Doubts about maximum variation in participants and data saturation - Interesting results but need to be presented in a better way Minor: - Check for grammar and typos (for example, lines 119, 133, 530…) Introduction: The argument is built well and the objective stated clearly. Minor: - You mention that BV being sexually transmitted is a controversial and debated idea and then you elaborate more on the possibility of it being sexually transmitted. I would like to see a short sentence summarising what the other lines of thought are if BV is not sexually transmitted, eg ethnic/racial pre-dispositions to BV, BV in women prior to sexual debut ++ Methods: I liked how reflexivity regarding the interviewer’s gender and profession was considered during the interview process. Major - Ethics statements needs more elaboration on confidentiality and verbal consent. How was confidentiality ensured? Was verbal consent taken when setting up an interview time or just before the interview began? - In Table 1, one of the eligibility criteria listed was “consented to audio recording of interview” Justify this criteria. Why was this important? If it is a sensitive/private topic then perhaps this introduced a bias in the group that agreed to speak with you as perhaps not everyone wants to be audio recorded even though they may not mind participating in the study. If you agree about potentially biased selection of respondents, include in limitations. If you disagree, explain a bit why this was a good approach for the current setting. - Study setting is missing from methods. All I know is that a hospital in Victoria gave the ethical approval, but where was the study conducted? Later I read about phone interviews, but it needs to be clear in the methods where they were conducted. - What was the age distribution of the respondents? And ethnicities? How did you ensure maximum variation in the respondents when you purposely selected them? Were your respondents varied enough to conclude saturation? Minor - It is unclear to me what you mean by “explore consciousness” on line 113 - Line 177, the acronym JB appears for the first time… who is this person? Why was this person an appropriate person to conclude data saturation? Explain - You conducted phone interviews about a potentially private/sensitive topic – was anything done to build trust? - Line 175: Influence on what? - Results You have some interesting and useful findings to fill a knowledge gap. Major: - Table 4 is difficult to read, also this isn’t a case study from what I can tell, so presenting the variation as text and explaining it will be better. - Analysis needs some more work and cleaning up for example, line 231/232: how are 3.1 and 3.2 different? 3.2 seems more about manhood/perceptions of masculinity than “the supportive man” while 4.1.1 also speaks of “manhood” a bit differently. - Page 16/17: Case 2: “This participant demonstrated extremely high levels of STI stigma and traditional masculinity”. Here ‘stigma’ and ‘traditional masculinity’ need to be contextualised and defined. You do it a bit in your discussion but these concepts can be defined in the methods and theory section. - Line 650-653: From the data presented here, it seems to me that their sex lives DO matter to them - Minor: - Table 2 “How would they like to receive information” – what information? Specify. - Line 194, You write about JB and CV being experienced social researchers. This should come earlier when or before JB was first introduced - Line 200, How were the 20 men chosen to be contacted? Were there only 20 who contacted you with interest in being in a study? When you stopped at 11, did you contact the remaining 9 to inform them why they were not contacted further? - Table 3. Did you mean “Average length of relationship”? - The list of themes and sub themes is unnecessary - Check for repetition in the results - Discussion Major: - Check for repetition Minor: Reviewer #2: This is a really well written article about men's experiences of BV and their views on male partner treatment. It is a qualitative study conducted alongside a RCT where women with confirmed BV were enrolled, as well as male partners. A few comments: It would be interesting to know a bit more about what the Step Up Trial consisted of for the male partners, beyond the eligibility requirements. Was it treatment only or were there other aspects of the study (e.g. education). Consent process: Did the study team require written/electronic informed consent or verbal consent? A bit more detail on the consent process in the text would be helpful. Recruitment: In the analysis, the authors state that they reached data saturation after 11 participants had been interviewed but, in the results section, it seems that the others who were not interviewed (the remaining 9 of the 20 contacted) were not interested in participating. Had data saturation not been reached, what would have happened? Methods: 20-60 minute interviews seem quite short for lived experience research, what was the average length? Results: What was the sexual identification of the 1 participant who did not identify as heterosexual? Is there a better way to format the case scenarios? It was difficult to read side by side over several pages. Discussion: Regarding your point about local categories of illnesses and its impact on the disease and treatment experiences (and acceptance), I wonder if there is any literature about the perceptions of men regarding vaccination for HPV and about stigma related to HPV care seeking. This literature, if it exists, might be interesting to explore. I also think that the finding about BV not being classified as a STI is important to think about when working out how to communicate with the public about treatment and decision making as well as the case of the man who had symptoms. Additionally, I do think that further research is needed into reasons men decline MPT beyond the hypothetical reasons listed by those who had already accepted it. The group interviewed were a very specific population as they were enrolled in studies about the topic with partners who were also enrolled in studies. Their views might be wildly different than those who refused participation and within the community more broadly but the finding from this study could be used to inform data collection in other studies. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
“It’s just an issue and you deal with it… you just deal with it, you move on and you do it together.”: Male experiences of Bacterial Vaginosis and the acceptability of associated male partner treatment. PONE-D-20-05638R1 Dear Dr. Wigan, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tania Crucitti Academic Editor PLOS ONE Additional Editor Comments (optional): A typo occured in line 55 Bactria should read Bacteria, line 723 partners should read partners' Please also check that names of bacteria are written in italic, for example line 857 Gardnerella vaginalis Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-05638R1 “It’s just an issue and you deal with it… you just deal with it, you move on and you do it together.”: Men’s experiences of Bacterial Vaginosis and the acceptability of male partner treatment Dear Dr. Wigan: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Tania Crucitti Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .